11:50 AM EST - Arch Biopartners, Inc. : Announced today the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent 9,464,114 titled, "Peptides that Block Leukocyte Recruitment and Methods of Use". This is the first patent issued protecting the composition and method of use for Metablok™, the Company's drug candidate targeting inflammation, sepsis and cancer metastasis. Arch Biopartners, Inc.
shares V.ACH are trading up $0.01 at $0.47.
